NORI Research Studies
- Genentech – Harbor
Comparing the efficacy of high dose Lucentis® versus Standard of Care Lucentis® in patients who have Wet Macular Degeneration
- CATT
Comparing the efficacy of Lucentis® vs. Avastin® for Wet Macular Degeneration
- Regeneron AMD
Evaluating the efficacy of VEGF trap for Wet Macular Degeneration
- Novartis DME
Comparing the efficacy of oral amlodipine vs. oral aliskiren for Diabetic Macular Edema
- Thrombogenics
Evaluating the efficacy of microplasmin to induce Posterior Vitreous Detachment
- Regeneron CRVO
Evaluating the efficacy of VEGF trap for Macular Edema associated with Central Retinal Vein Occlusion
- eyeGene™
Genetic DNA blood testing for multiple retinal diseases:
- Aniridia and other developmental eye anomalies
- Juvenile X-linked Retinoschisis
- Axenfeld - Rieger Syndrome
- Leber Hereditary Optic Neuropathy (LHON)
- Best Disease
- Lowe Syndrome
- Bietti's Crystalline Corneal-Retinal Dystrophy
- Meesman's Epithelial Dystrophy
- Choroideremia
- Microphthalmia and Anophthalmia
- Cone Rod Dystrophy
- Neuropathy, Ataxia, and Retinitis Pigmentosa (NARP)
- Congenital Cranial Dysinnervation Diseases (CCDD)
- X-linked Ocular Albinism
- Congenital Stationary Night Blindness
- Optic Atrophy Type 1
- Corneal Anterior Stromal Dystrophies
- Pantothenate Kinase-associated Neuropathy (PKAN)
- Doyne Honeycomb Dystrophy
- Pattern Dystrophy
- Familial Exudative Vitreal Retinopathy
- Retinitis Pigmentosa (RP) and Retinal Degenerations
- Glaucoma
- Retinoblastoma
- Hermansky-Pudlak Syndrome
|

General Criteria
for
inclusion into clinical studies:
Good
General Health
Available
for
Multiple Clinic Visits |
|